Real-time enrollment status for this recurrent astrocytoma, idh-mutant, grade 3 clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 6:05 PM UTC
| NCT Number | NCT06815029 |
| Recruiting Status | Recruiting |
| Condition | Recurrent Astrocytoma, IDH-Mutant, Grade 3 |
| Phase | PHASE1 |
| Target Enrollment | 27 participants |
| Active Locations | 1 sites in the US |
| Sponsor | City of Hope Medical Center |
| Last Updated on CT.gov | June 29, 2026 (2 weeks ago) |
As of July 18, 2026: Clinical trial NCT06815029 is currently recruiting participants. This phase1 study for recurrent astrocytoma, idh-mutant, grade 3 is actively seeking new participants at 1 location across the United States. The study is sponsored by City of Hope Medical Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06815029 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06815029 was last updated 2 weeks ago (June 29, 2026). HelloStudys verifies this status automatically.